Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (101-110 of 218) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationMark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
Scientific Reports|May 31, 2020
Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysisSeock-Ah Im, Binghe Xu, Wei Li, et al.
Environmental Science & Technology|October 24, 2009
Perinatal exposure to perchlorate. thiocyanate, and nitrate in New Jersey mothers and newbornsBenjamin C Blount, David Q Rich, Liza Valentin-Blasini, et al.
Breast Cancer Research and Treatment|August 25, 2018
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRIJanice S Sung, Adriana D Corben, Jennifer D Brooks, et al.
Journal of the National Cancer Institute|September 2, 2016
ResponseAmanda B Spurdle, Susan Domchek, Mark Robson, et al.
Journal of the American Geriatrics Society|July 27, 2006
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Anju Hurria, Enid Zuckerman, et al.
European Journal of Human Genetics : EJHG|April 29, 2018
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsYvonne Bombard, Marc Clausen, Chloe Mighton, et al.
The Science of the Total Environment|December 20, 2005
Children's residential exposure to chlorpyrifos: application of CPPAES field measurements of chlorpyrifos and TCPy within MENTOR/SHEDS-Pesticides modelParomita Hore, Valerie Zartarian, Jianping Xue, et al.
JCO Precision Oncology|September 14, 2020
Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer RiskElisha Hughes, Placede Tshiaba, Shannon Gallagher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 3, 2020
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinomaRaza Syed Hoda, Edi Brogi, Carlos Henrique Dos Anjos, et al.
Pageof 22

Showing results (101-110 of 218) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationMark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
Scientific Reports|May 31, 2020
Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysisSeock-Ah Im, Binghe Xu, Wei Li, et al.
Environmental Science & Technology|October 24, 2009
Perinatal exposure to perchlorate. thiocyanate, and nitrate in New Jersey mothers and newbornsBenjamin C Blount, David Q Rich, Liza Valentin-Blasini, et al.
Breast Cancer Research and Treatment|August 25, 2018
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRIJanice S Sung, Adriana D Corben, Jennifer D Brooks, et al.
Journal of the National Cancer Institute|September 2, 2016
ResponseAmanda B Spurdle, Susan Domchek, Mark Robson, et al.
Journal of the American Geriatrics Society|July 27, 2006
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Anju Hurria, Enid Zuckerman, et al.
European Journal of Human Genetics : EJHG|April 29, 2018
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsYvonne Bombard, Marc Clausen, Chloe Mighton, et al.
The Science of the Total Environment|December 20, 2005
Children's residential exposure to chlorpyrifos: application of CPPAES field measurements of chlorpyrifos and TCPy within MENTOR/SHEDS-Pesticides modelParomita Hore, Valerie Zartarian, Jianping Xue, et al.
JCO Precision Oncology|September 14, 2020
Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer RiskElisha Hughes, Placede Tshiaba, Shannon Gallagher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 3, 2020
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinomaRaza Syed Hoda, Edi Brogi, Carlos Henrique Dos Anjos, et al.
Pageof 22